AIG
AVIR icon

American International Group’s Atea Pharmaceuticals AVIR Stock Holding History

American International Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,779
Closed -$153K – 258
2024
Q1 		$153K Sell
37,779
-325
-0.9% -$1.27K ﹤0.01% 2296
2023
Q4 		$116K Sell
38,104
-154
-0.4% -$466 ﹤0.01% 2473
2023
Q3 		$115K Buy
38,258
+1,360
+4% +$4.63K ﹤0.01% 2432
2023
Q2 		$138K Buy
36,898
+72
+0.2% +$270 ﹤0.01% 2384
2023
Q1 		$123K Buy
36,826
+733
+2% +$2.97K ﹤0.01% 2361
2022
Q4 		$174K Sell
36,093
-131
-0.4% -$663 ﹤0.01% 2202
2022
Q3 		$206K Buy
36,224
+512
+1% +$3.92K ﹤0.01% 2137
2022
Q2 		$254K Buy
35,712
+3,647
+11% +$24.9K ﹤0.01% 2033
2022
Q1 		$232K Sell
32,065
-2,257
-7% -$15.3K ﹤0.01% 2150
2021
Q4 		$307K Sell
34,322
-1,027
-3% -$16K ﹤0.01% 2102
2021
Q3 		$1.24M Sell
35,349
-840
-2% -$23.3K 0.01% 1316
2021
Q2 		$777 Buy
36,189
+27,737
+328% +$833K ﹤0.01% 1651
2021
Q1 		$522 Buy
8,452
+23
+0.3% +$1.55K ﹤0.01% 1815
2020
Q4 		$352 Buy
+8,429
New +$272K ﹤0.01% 1949

Other funds holding AVIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

American International Group's AVIR Position: Q2 2024 in Review

American International Group sold out of Atea Pharmaceuticals (AVIR) in Q2 2024, closing a stake of 37,779 shares — an estimated $153K sold.

American International Group first reported a position in AVIR in Q4 2020 and held it in 14 quarters. The position peaked at $1.24M in Q3 2021. 105 funds tracked by Wall St. Rank hold AVIR as of Q2 2024.

  • American International Group reported no remaining Atea Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 37,779 Atea Pharmaceuticals shares in Q2 2024, an estimated $153K.
  • American International Group first reported a position in Atea Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • American International Group's Atea Pharmaceuticals position peaked at $1.24M in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.